Global Infusion Therapy Market to Exceed US$ 78.9 Billion by 2031, Driven by Chronic Disease Burden and Home Healthcare Adoption

The global Infusion Therapy Market is poised for strong growth over the next decade, fueled by the increasing prevalence of chronic diseases, rapid technological advancements in infusion devices, and the expanding adoption of home-based healthcare solutions. According to the latest market analysis, the industry was valued at US$ 41.7 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 6.7% from 2022 to 2031, reaching more than US$ 78.9 billion by the end of 2031.

Explore core findings and critical insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=42137

Market Overview: Infusion therapy involves the administration of medications, fluids, nutrients, or biologics directly into a patient's body through non-oral routes, such as intravenous (IV), intramuscular, or epidural pathways. This form of therapy is widely used when oral medications are ineffective or impractical, particularly in the treatment of cancer, cardiovascular diseases, gastrointestinal disorders, neurological conditions, immune deficiencies, and severe infections.
In recent years, infusion therapy has evolved beyond traditional hospital settings. The emergence of home infusion therapy, supported by portable infusion pumps and user-friendly kits, has transformed patient care by improving convenience, reducing hospital stays, and lowering the risk of hospital-acquired infections (HAIs). As healthcare systems worldwide prioritize cost efficiency and patient-centric care models, infusion therapy continues to gain traction across both developed and emerging markets.

Key Market Growth Drivers

Rising Prevalence of Chronic Diseases
The increasing global burden of chronic diseases is a primary driver of the infusion therapy market. Cancer, cardiovascular diseases (CVDs), diabetes, and autoimmune disorders require long-term, complex treatment regimens, many of which rely on infusion-based drug delivery.

• Cancer: According to the World Health Organization (WHO), cancer accounted for nearly 10 million deaths globally in 2020, making it one of the leading causes of mortality worldwide. Chemotherapy and supportive cancer treatments are heavily dependent on infusion therapy.
• Cardiovascular Diseases: CVDs remain the leading cause of death globally, accounting for 17.9 million deaths in 2019, with infusion therapies playing a critical role in acute and chronic cardiac care.

• Diabetes and Immune Disorders: The growing number of patients requiring IV medications and nutritional support further strengthens market demand.
Reduction of Human Errors through Advanced Infusion Pumps
Technological innovation has significantly enhanced the safety and accuracy of infusion therapy. Smart infusion pumps, equipped with drug libraries and dose error reduction systems, minimize medication errors and improve patient outcomes. Advanced systems such as large-volume and small-volume pumps enable precise delivery of nutrients, hormones, and chemotherapy drugs, reducing the risk of adverse events.

Growing Demand for Portable and Home Infusion Solutions
Portable and ambulatory infusion pumps have gained widespread adoption, particularly in homecare settings. Studies indicate that over 90% of hospitalized patients in the U.S. receive IV medications, many of which are delivered through portable infusion systems. The convenience and cost-effectiveness of home infusion therapy are key factors accelerating market expansion.

Market Challenges and Opportunities

Challenges
Despite strong growth prospects, the infusion therapy market faces several challenges, including:
• High initial costs of advanced infusion devices
• Stringent regulatory requirements for product approvals
• Risk of complications such as infections or catheter-related issues

Opportunities
On the other hand, the market offers significant opportunities for innovation and expansion:
• Development of cost-effective, user-friendly home infusion kits
• Integration of digital health technologies and remote monitoring
• Expansion into emerging markets with improving healthcare infrastructure

Analysis of Key Players and Strategies

The global infusion therapy market is highly competitive, with leading players focusing on mergers & acquisitions, strategic partnerships, product launches, and technological innovation to strengthen their market presence.
Key companies operating in the market include:

• B. Braun Melsungen AG
• Medtronic plc
• Becton, Dickinson and Company
• ICU medical (Smiths Medical)
• Baxter International, Inc.
• Polymedicure
• BIO-MED
• Terumo Medical Corporation
• MEDIPRIM GmbH
• Fresenius Kabi
• Cardinal Health
These companies are actively expanding their product portfolios and geographic reach to capitalize on emerging opportunities in homecare and ambulatory infusion therapy.

Buy this Premium Research Report and explore vital industry trends - https://www.transparencymarketresearch.com/checkout.php?rep_id=42137<ype=S

Recent Developments

• February 2022: B. Braun received FDA approval for its Daytona Beach Pharmaceutical Manufacturing Site in the U.S. This facility is part of the company's commitment to invest over US$ 1 billion to enhance IV fluid production capacity and address supply shortages. The approval strengthens B. Braun's manufacturing footprint across both U.S. coasts.

Investment Landscape and ROI Outlook

Investment in the infusion therapy market has increased steadily, particularly in North America and Asia Pacific. Growing healthcare expenditure, favorable reimbursement policies, and rising demand for advanced therapies have created a favorable investment environment. From an ROI perspective, companies investing in smart infusion technologies, homecare solutions, and emerging markets are expected to achieve attractive long-term returns.

Market Segmentation

By Product
• Infusion Pumps
o Ambulatory Infusion Pumps
o Stationary Infusion Pumps
o Syringe Infusion Pumps
o Disposable Pumps
o Large Volume Pumps
o Elastomeric Pumps
• Infusion Sets
• Accessories (largest share, over 35% in 2021)

By Indication
• Cancer
• Gastrointestinal Diseases
• Congestive Heart Failure
• Rheumatoid Arthritis
• Hemophilia
• Immune Deficiencies
• Others

By Therapy
• Antibiotic/Antiviral (dominant segment)
• Chemotherapy
• Nutrition
• Hydration
• Pain Management
• Anti-coagulation
• Anti-emetics

By End-user
• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Homecare Settings

By Region
• North America (largest market share)
• Europe
• Asia Pacific (fastest-growing region)
• Latin America
• Middle East & Africa

Regional Insights

North America dominated the global infusion therapy market in 2021, driven by high prevalence of chronic diseases, advanced healthcare infrastructure, and strong investment in medical technologies. Asia Pacific is expected to witness the fastest growth during the forecast period due to rapid adoption of new technologies, expanding geriatric population, and improving access to healthcare services.

Why Buy This Report?

• Gain comprehensive insights into market size, growth trends, and future outlook
• Identify key growth drivers, challenges, and opportunities
• Analyze competitive landscape and key player strategies
• Understand detailed market segmentation by product, indication, therapy, end-user, and region
• Make informed strategic and investment decisions

Frequently Asked Questions (FAQs)

1. How big was the global infusion therapy market in 2021?
The market was valued at US$ 41.7 billion in 2021.

2. How big will the market be by 2031?
It is projected to reach more than US$ 78.9 billion by 2031.

3. What is the expected CAGR during the forecast period?
The market is expected to grow at a CAGR of 6.7% from 2022 to 2031.

4. What are the key trends driving market growth?
Rising prevalence of chronic diseases and reduction of human errors through advanced infusion pumps.

5. Which region holds the largest market share?
North America is expected to account for the largest share during the forecast period.

Explore Latest Research Reports by Transparency Market Research:

Transfection Reagents and Equipment Market: https://www.transparencymarketresearch.com/transfection-reagents-equipment-market.html

Cardiac Prosthetic Devices Market: https://www.transparencymarketresearch.com/cardiac-prosthetic-market.html

Rigid Laparoscopes Market: https://www.transparencymarketresearch.com/rigid-laparoscopes-market.html

Ultrasensitive Molecular Amplification Market: https://www.transparencymarketresearch.com/ultrasensitive-molecular-amplification-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.